The Quiet Embryo Hypothesis: 20 years on.

amino acids blastocyst embryo metabolism pyruvate

Journal

Frontiers in physiology
ISSN: 1664-042X
Titre abrégé: Front Physiol
Pays: Switzerland
ID NLM: 101549006

Informations de publication

Date de publication:
2022
Historique:
received: 18 03 2022
accepted: 08 04 2022
entrez: 31 5 2022
pubmed: 1 6 2022
medline: 1 6 2022
Statut: epublish

Résumé

This article revisits the hypothesis, proposed in 2002, that the successful development of oocytes and preimplantation mammalian embryos is associated with a metabolism which is "quiet" rather than "active", within limits which had yet to be defined. A distinction was drawn between Functional Quietness, Loss of quietness in response to stress and Inter-individual differences in embryo metabolism and here we document applications of the hypothesis to other areas of reproductive biology. In order to encompass the requirement for "limits" and replace the simple distinction between "quiet" and "active", evidence is presented which led to a re-working of the hypothesis by proposing the existence of an optimal range of metabolic activity, termed a "Goldilocks zone", within which oocytes and embryos with maximum developmental potential will be located. General and specific mechanisms which may underlie the Goldilocks phenomenon are proposed and the added value that may be derived by expressing data on individual embryos as distributions rather than mean values is emphasised especially in the context of the response of early embryos to stress and to the concept of the Developmental Origins of Health and Disease. The article concludes with a cautionary note that being "quietly efficient" may not always ensure optimal embryo survival.

Identifiants

pubmed: 35634152
doi: 10.3389/fphys.2022.899485
pii: 899485
pmc: PMC9131187
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

899485

Informations de copyright

Copyright © 2022 Leese, Brison and Sturmey.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Placenta. 2017 Aug;56:14-18
pubmed: 28187917
Mol Reprod Dev. 2010 Mar;77(3):285-96
pubmed: 20058302
Theriogenology. 2005 May;63(8):2254-68
pubmed: 15826688
Biol Reprod. 2012 May 31;86(5):165, 1-12
pubmed: 22378762
PLoS Genet. 2015 Jun 03;11(6):e1005241
pubmed: 26039092
Theriogenology. 2007 Jan 1;67(1):21-31
pubmed: 17109946
Hum Reprod. 1998 Dec;13 Suppl 4:184-202
pubmed: 10091069
Mol Reprod Dev. 2007 Oct;74(10):1345-53
pubmed: 17342740
Dev Biol. 1973 Jul;33(1):171-84
pubmed: 4789598
Hum Reprod. 2002 Apr;17(4):999-1005
pubmed: 11925397
Mol Reprod Dev. 2016 Sep;83(9):748-754
pubmed: 27465801
Hum Reprod. 2010 Mar;25(3):605-12
pubmed: 20085915
Cell. 2013 Mar 28;153(1):56-69
pubmed: 23540690
Mol Reprod Dev. 2012 Sep;79(9):613-25
pubmed: 22778065
Differentiation. 2006 Feb;74(1):11-8
pubmed: 16466396
Biol Reprod. 1997 May;56(5):1088-96
pubmed: 9160705
PLoS One. 2013 Aug 15;8(8):e67834
pubmed: 23967049
Mol Reprod Dev. 2009 Mar;76(3):231-8
pubmed: 18618608
Hum Reprod. 2009 Jan;24(1):81-91
pubmed: 18835872
J Assist Reprod Genet. 2011 Jun;28(6):517-24
pubmed: 21625966
Mol Hum Reprod. 2008 Dec;14(12):667-72
pubmed: 19019836
Mol Hum Reprod. 2010 Aug;16(8):557-69
pubmed: 20571076
PLoS One. 2010 Apr 21;5(4):e10258
pubmed: 20422011
Hum Reprod. 2007 Mar;22(3):829-35
pubmed: 17138583
Am J Clin Nutr. 2011 Dec;94(6 Suppl):1980S-1985S
pubmed: 21613560
Hum Reprod. 2007 Dec;22(12):3047-50
pubmed: 17956925
BMJ Open. 2019 Nov 27;9(11):e027767
pubmed: 31780584
J Assist Reprod Genet. 1993 Jan;10(1):21-30
pubmed: 8499675
Biol Reprod. 2014 Oct;91(4):98
pubmed: 25187529
Hum Reprod. 2004 Oct;19(10):2319-24
pubmed: 15298971
J Biol Eng. 2013 Feb 20;7(1):6
pubmed: 23421993
Bioessays. 2002 Sep;24(9):845-9
pubmed: 12210521
Hum Reprod. 2020 Sep 1;35(9):2004-2016
pubmed: 32829415
Int J Dev Biol. 2012;56(10-12):799-808
pubmed: 23417402
BMC Med. 2018 Nov 28;16(1):224
pubmed: 30482203
PLoS One. 2012;7(7):e41424
pubmed: 22848492

Auteurs

Henry J Leese (HJ)

Centre for Atherothrombosis and Metabolic Disease, Hull York Medical School, University of Hull, Hull, United Kingdom.

Daniel R Brison (DR)

Department of Reproductive Medicine, Old St. Mary's Hospital, Manchester University NHS Foundation Trust, Manchester, United Kingdom.
Division of Developmental Biology and Medicine, School of Medical Sciences, Faculty of Biology, St Mary's Hospital, Medicine and Health, the University of Manchester, Manchester University NHS Foundation Trust, Manchester, United Kingdom.

Roger G Sturmey (RG)

Centre for Atherothrombosis and Metabolic Disease, Hull York Medical School, University of Hull, Hull, United Kingdom.
Division of Developmental Biology and Medicine, School of Medical Sciences, Faculty of Biology, St Mary's Hospital, Medicine and Health, the University of Manchester, Manchester University NHS Foundation Trust, Manchester, United Kingdom.

Classifications MeSH